Israel - venäjä - Ministry of Health

pfizer pharmaceuticals israel ltd - somatropin recombinant 36 iu/ml - lyophilized powder for injection - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth witght and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.

Israel - venäjä - Ministry of Health

teva pharmaceutical indust.ltd - anastrozole 1 mg - tablets - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

Israel - venäjä - Ministry of Health

teva pharmaceutical indust.ltd - letrozole 2.5 mg - tablets - letrozole - letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Valko-Venäjä - venäjä - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

dia.metra s.r.l., ИТАЛИЯ -

Valko-Venäjä - venäjä - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

dia.metra s.r.l., ИТАЛИЯ -

Valko-Venäjä - venäjä - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

dia.metra s.r.l., ИТАЛИЯ -

Valko-Venäjä - venäjä - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

dia.metra s.r.l., ИТАЛИЯ -

Valko-Venäjä - venäjä - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

boditech med inc., РЕСПУБЛИКА КОРЕЯ -